Thromboprophylaxis with standard- vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulationResearch article Published on 2022-11-012022-10-05 Journal: Journal of clinical epidemiology [Category] [DOI] 10.1016/j.jclinepi.2022.08.006 [Article Type] Research article
Severe COVID-19 increases the risk of schizophreniaShort communication Published on 2022-11-012022-10-05 Journal: Psychiatry research [Category] [DOI] 10.1016/j.psychres.2022.114809 [Article Type] Short communication
Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivorsArticle Published on 2022-11-012022-11-15 Journal: Pain [Category] [DOI] 10.1097/j.pain.0000000000002608 PMC 바로가기
Does vitamin D supplementation reduce COVID-19 severity?: a systematic reviewArticle Published on 2022-10-252022-11-16 Journal: QJM: An International Journal of Medicine [Category] [DOI] 10.1093/qjmed/hcac040 PMC 바로가기
A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19Article Published on 2022-10-212022-11-16 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-22711-1 PMC 바로가기
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patientsArticle Published on 2022-10-182022-11-15 Journal: Cell Reports Medicine [Category] [DOI] 10.1016/j.xcrm.2022.100779 PMC 바로가기
Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19Article Published on 2022-10-062022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0275391 PMC 바로가기
Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variantsArticle Published on 2022-10-012022-11-16 Journal: Headache [Category] [DOI] 10.1111/head.14398 PMC 바로가기
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19Article Published on 2022-09-142022-11-15 Journal: Critical Care [Category] [DOI] 10.1186/s13054-022-04153-3 PMC 바로가기
Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptableDiscussion Published on 2022-09-012022-10-05 Journal: European journal of internal medicine [Category] [DOI] 10.1016/j.ejim.2022.06.018 [Article Type] Discussion